Palvella Therapeutics (PVLA) Operating Margin Growth (1y) (2015 - 2024)
Palvella Therapeutics (PVLA) Operating Margin Growth (1y) (2015 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1,552.00 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1,536.00 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -170.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1,049.00 |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Palvella Therapeutics | 318.78 Mn | 56.92 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | -254,718.00 |
| Dec 31, 2023 | 792,996.00 |
| Sep 30, 2023 | 465,579.00 |
| Jun 30, 2023 | 537,116.00 |
| Mar 31, 2023 | -70,383.00 |
| Dec 31, 2022 | -827,776.00 |
| Sep 30, 2022 | -424,766.00 |
| Jun 30, 2022 | -311,107.00 |
| Mar 31, 2022 | -2,895.00 |
| Dec 31, 2021 | -48,136.00 |
| Sep 30, 2021 | 3,561.00 |
| Jun 30, 2021 | -220,721.00 |
| Mar 31, 2021 | -984.00 |
| Dec 31, 2020 | 35,879.00 |
| Sep 30, 2020 | -48,497.00 |
| Jun 30, 2020 | 18,678.00 |
| Mar 31, 2020 | 9,594.00 |
| Dec 31, 2019 | 210,030.00 |
| Sep 30, 2019 | 7,426.00 |
| Jun 30, 2019 | -21,018.00 |